Dr. Michael D. Alvarado, MD

Dr. Alvarado practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Alvarado's NPI, 1922029354, was assigned on July 21, 2006. Dr. Alvarado graduated from Geisel School Of Medicine At Dartmouth in 1998. Dr. Alvarado holds California license A96393.

Dr. Alvarado's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Alvarado's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Alvarado to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alvarado practices. Vendor and product names are available with a free account.

Surgery is Dr. Alvarado's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Alvarado is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Alvarado's licenses on file in 3 states: California, Florida and New Hampshire.

Dmand AI lists breast reconstruction, breast surgery, cancerous skin growth removal, mastectomy and removal of damaged skin or skin graft among the conditions Dr. Alvarado treats.

CMS data shows 303 Medicare services from Dr. Alvarado across 10 procedure codes in 2024, for 117 Medicare patients. Medicare paid $64,149 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Alvarado in 2024. The largest group is 65 to 74, with 58 patients. 68% of them have high blood pressure, and 66% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alvarado's median patient age at 64, with 71% women.

In 2021, Dr. Alvarado wrote 31 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $190 in total drug cost. In 2020, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Alvarado for performance year 2024, reported as part of a group. Dr. Alvarado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alvarado as offering telehealth. CMS counts 52 procedures of melanoma (skin cancer) excision by Dr. Alvarado, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 96 papers to Dr. Alvarado, published from 2006 to 2024. 2020 was the busiest year, with 12. The most frequent topics are Breast Neoplasms, Mastectomy and Mammaplasty. Dr. Alvarado has published most often in Ann Surg Oncol. Dr. Alvarado's most frequent co-authors are Laura J. Esserman, MD, Cheryl A. Ewing, MD and Rita A. Mukhtar, MD.

Dmand AI links Dr. Alvarado to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 301 general payments to Dr. Alvarado from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 46% of the total. Endomagnetics Ltd paid the most, $138,845.

Dmand AI lists 2 awards for Dr. Alvarado, most recently Regional Top Doctor in 2014.

Dr. Alvarado graduated from Geisel School Of Medicine At Dartmouth in 1998. Dr. Alvarado is a member of ACS.

Dr. Alvarado is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.